Mouse models for human otitis media

Brain Research

Volumn 1277, Issue , 2009, Pages 90-103

  Trune, Dennis R ^a   Zheng, Qing Yin ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Etiology; Genetic predisposition to disease; Immunology; Mice; Otitis media

Indexed keywords

BACTERIAL VACCINE; TOLL LIKE RECEPTOR;

ANIMAL MODEL; DISEASE PREDISPOSITION; GENE FUNCTION; GENE SEQUENCE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; INNER EAR; MOUSE; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOTHERAPY, ACTIVE; MICE; OTITIS MEDIA; TOLL-LIKE RECEPTORS;

MUS;

EID: 67649819586     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.02.047     Document Type: Review

References (197)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Akira S. Toll-like receptors and innate immunity. Adv. Immunol. 78 (2001) 1-56
3. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
4. Alho O.P., Koivu M., and Sorri M. What is an 'otitis-prone' child? Int. J. Pediatr. Otorhinolaryngol. 21 (1991) 201-209
5. Alper C.M., Andalibi A., Bakaletz L.O., Buchman C., Caye-Thomasen P., Hellstrom S.O., Herman P., Hermansson A., Hussl B., Iino Y., Kawauchi H., Paparella M.M., Sando I., Swarts J.D., and Takasaka T. Recent advances in otitis media. 4. Anatomy, cell biology, pathology, and animal models. Ann. Otol. Rhinol. Laryngol. Suppl. 188 (2002) 36-51
6. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., and Schwartz D.A. Tlr4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
7. Asahi Y., Yoshikawa T., Watanabe I., Iwasaki T., et al. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168 (2002) 2930-2938
8. Austin C.P., Battey J.F., Bradley A., Bucan M., Capecchi M., Collins F.S., Dove W.F., Duyk G., Dymecki S., Eppig J.T., Grieder F.B., Heintz N., Hicks G., Insel T.R., Joyner A., Koller B.H., Lloyd K.C., Magnuson T., Moore M.W., Nagy A., Pollock J.D., Roses A.D., Sands A.T., Seed B., Skarnes W.C., Snoddy J., Soriano P., Stewart D.J., Stewart F., Stillman B., Varmus H., Varticovski L., Verma I.M., Vogt T.F., von Melchner H., Witkowski J., Woychik R.P., Wurst W., Yancopoulos G.D., Young S.G., and Zambrowicz B. The knockout mouse project. Nat. Genet. 36 (2004) 921-924
9. Auwerx J., Avner P., Baldock R., Ballabio A., Balling R., Barbacid M., Berns A., Bradley A., Brown S., Carmeliet P., Chambon P., Cox R., Davidson D., Davies K., Duboule D., Forejt J., Granucci F., Hastie N., de Angelis M.H., Jackson I., Kioussis D., Kollias G., Lathrop M., Lendahl U., Malumbres M., von Melchner H., Muller W., Partanen J., Ricciardi-Castagnoli P., Rigby P., Rosen B., Rosenthal N., Skarnes B., Stewart A.F., Thornton J., Tocchini-Valentini G., Wagner E., Wahli W., and Wurst W. The European dimension for the mouse genome mutagenesis program. Nat. Genet. 36 (2004) 925-927
10. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., and Sher A. Tlr9 regulates th1 responses and cooperates with TLR2 in mediating optimal resistance to mycobacterium tuberculosis. J. Exp. Med. 202 (2005) 1715-1724
11. Bafica A., Santiago H.C., Goldszmid R., Ropert C., Gazzinelli R.T., and Sher A. Cutting edge: TLR9 and TLR2 signaling together account for myd88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177 (2006) 3515-3519
12. Bakaletz L.O., White G.J., Post J.C., and Ehrlich G.D. Blinded multiplex PCR analyses of middle ear and nasopharyngeal fluids from chinchilla models of single- and mixed-pathogen-induced otitis media. Clin. Diagn. Lab. Immunol. 5 (1998) 219-224
13. Bakaletz L.O., Juhn S.K., Jung T.T., and Li J.D. Recent advances in otitis media. 5. Molecular biology and biochemistry. Ann. Otol. Rhinol. Laryngol. Suppl. 188 (2002) 52-61
14. Ball S.S., Prazma J., Dais C.G., Triana R.J., and Pillsbury H.C. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann. Otol. Rhinol. Laryngol. 106 (1997) 633-639
15. Barbaric I., Wells S., Russ A., and Dear T.N. Spectrum of enu-induced mutations in phenotype-driven and gene-driven screens in the mouse. Environ. Mol. Mutagen 48 (2007) 124-142
16. Beghetto E., Gargano N., Ricci S., Garufi G., Peppoloni S., Montagnani F., Oggioni M., Pozzi G., and Felici F. Discovery of novel streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol. Lett. 262 (2006) 14-21
17. Ben J., Jabs E.W., and Chong S.S. Genomic, cDNA and embryonic expression analysis of zebrafish IRF6, the gene mutated in the human oral clefting disorders Van der Woude and popliteal pterygium syndromes. Gene Expr. Patterns 5 (2005) 629-638
18. Bluestone C.D., and Klein J.O. Otitis media in infants and children, vol (2001), W. B. Saunders, Philadelphia, PA
19. Bradley A., Evans M., Kaufman M.H., and Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309 (1984) 255-256
20. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25 (2007) 5467-5484
21. Briles D.E., Hollingshead S.K., Nabors G.S., Paton J.C., and Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by streptococcus pneumoniae. Vaccine 19 (2000) S87-95
22. Brodie H.A., Chang P.S., and Chole R.A. Dexamethasone inhibition of the development of dysplastic bony lesions in lp/j mice. Ann. Otol. Rhinol. Laryngol. 102 (1993) 814-817
23. Brown S.D., and Hardisty R.E. Mutagenesis strategies for identifying novel loci associated with disease phenotypes. Semin. Cell Dev. Biol. 14 (2003) 19-24
24. Casselbrant M.L., Mandel E.M., Fall P.A., Rockette H.E., Kurs-Lasky M., Bluestone C.D., and Ferrell R.E. The heritability of otitis media: a twin and triplet study. JAMA 282 (1999) 2125-2130
25. Chang B., Hawes N.L., Hurd R.E., Davisson M.T., Nusinowitz S., and Heckenlively J.R. Retinal degeneration mutants in the mouse. Vision Res. 42 (2002) 517-525
26. Chen D., McMichael J.C., VanDerMeid K.R., Hahn D., Mininni T., Cowell J., and Eldridge J. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64 (1996) 1900-1905
27. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappab, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45 (1999) 7-17
28. Chen R., Lim J.H., Jono H., Gu X.X., Kim Y.S., Basbaum C.B., Murphy T.F., and Li J.D. Nontypeable Haemophilus influenzae lipoprotein p6 induces muc5ac mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 324 (2004) 1087-1094
29. Chonmaitree T., Revai K., Grady J.J., Clos A., Patel J.A., Nair S., Fan J., and Henrickson K.J. Viral upper respiratory tract infection and otitis media complication in young children. Clin. Infect. Dis. 46 (2008) 815-823
30. Clark J.M., Brinson G., Newman M.K., Jewett B.S., Sartor B.R., Prazma J., and Pillsbury III H.C. An animal model for the study of genetic predisposition in the pathogenesis of middle ear inflammation. Laryngoscope 110 (2000) 1511-1515
31. Coates H.L., Morris P.S., Leach A.J., and Couzos S. Otitis media in aboriginal children: tackling a major health problem. Med. J. Aust. 177 (2002) 177-178
32. Cook D.N., Hollingsworth Jr. J.W., and Schwartz D.A. Toll-like receptors and the genetics of innate immunity. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 523-529
33. Cox R.D., and Brown S.D. Rodent models of genetic disease. Curr. Opin. Genet. Dev. 13 (2003) 278-283
34. Cripps A.W., Dunkley M.L., and Clancy R.L. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect. Immun. 62 (1994) 1427-1436
35. Cureoglu S., Schachern P.A., Paparella M.M., and Lindgren B.R. Cochlear changes in chronic otitis media. Laryngoscope 114 (2004) 622-626
36. Daly K.A. Epidemiology of otitis media. Otolaryngol. Clin. North Am. 24 (1991) 775-786
37. Daly K.A., Brown J.E., Lindgren B.R., Meland M.H., Le C.T., and Giebink G.S. Epidemiology of otitis media onset by six months of age. Pediatrics 103 (1999) 1158-1166
38. Daly K.A., Brown W.M., Segade F., Bowden D.W., Keats B.J., Lindgren B.R., Levine S.C., and Rich S.S. Chronic and recurrent otitis media: a genome scan for susceptibility loci. Am. J. Hum. Genet. 75 (2004) 988-997
39. Daly K.A., Hunter L.L., and Giebink G.S. Chronic otitis media with effusion. Pediatr. Rev. 20 (1999) 85-93 quiz 94
40. Davey M., Liu X., Ukai T., Jain V., Gudino C., Gibson III F.C., Golenbock D., Visintin A., and Genco C.A. Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J. Immunol. 180 (2008) 2187-2195
41. Depreux, F.F., Darrow, K., Conner, D.A., Eavey, R.D., Liberman, M.C., Seidman, C.E., Seidman, J.G., 2008. Eya4-deficient mice are a model for heritable otitis media. J. Clin. Invest. 118 (2), 651-658.
42. Doz E., Noulin N., Boichot E., Guenon I., Fick L., Le Bert M., Lagente V., Ryffel B., Schnyder B., Quesniaux V.F., and Couillin I. Cigarette smoke-induced pulmonary inflammation is TLR4/myd88 and il-1r1/MyD88 signaling dependent. J. Immunol. 180 (2008) 1169-1178
43. Ebmeyer J., Furukawa M., Pak K., Ebmeyer U., Sudhoff H., Broide D., Ryan A.F., and Wasserman S. Role of mast cells in otitis media. J. Allergy Clin. Immunol. 116 (2005) 1129-1135
44. Emonts M., Veenhoven R.H., Wiertsema S.P., Houwing-Duistermaat J.J., Walraven V., de Groot R., Hermans P.W., and Sanders E.A. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 120 (2007) 814-823
45. Emonts M., Wiertsema S.P., Veenhoven R.H., Houwing-Duistermaat J.J., Walraven V., de Groot R., Hermans P.W., and Sanders E.A. The 4 g/4 g plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media. Pediatrics 120 (2007) e317-323
46. Eriksson P.O., Li J., Ny T., and Hellstrom S. Spontaneous development of otitis media in plasminogen-deficient mice. Int. J. Med. Microbiol. 296 (2006) 501-509
47. Funke B., Epstein J.A., Kochilas L.K., Lu M.M., Pandita R.K., Liao J., Bauerndistel R., Schuler T., Schorle H., Brown M.C., Adams J., and Morrow B.E. Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects. Hum. Mol. Genet. 10 (2001) 2549-2556
48. Ghaheri B.A., Kempton J.B., Pillers D.A., and Trune D.R. Cochlear cytokine gene expression in murine acute otitis media. Laryngoscope 117 (2007) 22-29
49. Ghaheri B.A., Kempton J.B., Pillers D.A., and Trune D.R. Cochlear cytokine gene expression in murine chronic otitis media. Otolaryngol. Head Neck Surg. 137 (2007) 332-337
50. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
51. Giebink G.S. Otitis media: the chinchilla model. Microb. Drug Resist. 5 (1999) 57-72
52. Giebink G.S., Kurono Y., Bakaletz L.O., Kyd J.M., Barenkamp S.J., Murphy T.F., Green B., Ogra P.L., Gu X.X., Patel J.A., Heikkinen T., Pelton S.I., Hotomi M., and Karma P. Recent advances in otitis media. 6. Vaccine. Ann. Otol. Rhinol. Laryngol. Suppl. 194 (2005) 86-103
53. Gitiban N., Jurcisek J.A., Harris R.H., Mertz S.E., Durbin R.K., Bakaletz L.O., and Durbin J.E. Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus. J. Virol. 79 (2005) 6035-6042
54. Goycoolea M.V. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 121 (2001) 437-447
55. Green B.A., Vazquez M.E., Zlotnick G.W., Quigley-Reape G., Swarts J.D., Green I., Cowell J.L., Bluestone C.D., and Doyle W.J. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect. Immun. 61 (1993) 1950-1957
56. Gu H., Zou Y.R., and Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73 (1993) 1155-1164
57. Gu X.X., Chen J., Barenkamp S.J., Robbins J.B., Tsai C.M., Lim D.J., and Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (branhamella) catarrhalis. Infect. Immun. 66 (1998) 1891-1897
58. Gu X.X., Tsai C.M., Apicella M.A., and Lim D.J. Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae. Infect. Immun. 63 (1995) 4115-4120
59. Gu X.X., Tsai C.M., Ueyama T., Barenkamp S.J., Robbins J.B., and Lim D.J. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect. Immun. 64 (1996) 4047-4053
60. Guo Y.K., Xie D.H., and Yang X.M. [Morphological and functional alterations of ear in lysosomal neuraminidase gene deficient mouse]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40 (2005) 824-829
61. Ha U., Lim J.H., Jono H., Koga T., Srivastava A., Malley R., Pages G., Pouyssegur J., and Li J.D. A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of muc5ac mucin transcription by Streptococcus pneumoniae. J. Immunol. 178 (2007) 1736-1747
62. Haines D.C., Chattopadhyay S., and Ward J.M. Pathology of aging b6;129 mice. Toxicol. Pathol. 29 (2001) 653-661
63. Hardisty-Hughes R.E., Tateossian H., Morse S.A., Romero M.R., Middleton A., Tymowska-Lalanne Z., Hunter A.J., Cheeseman M., and Brown S.D. A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. Hum. Mol. Genet. 15 (2006) 3273-3279
64. Hardisty R.E., Erven A., Logan K., Morse S., Guionaud S., Sancho-Oliver S., Hunter A.J., Brown S.D., and Steel K.P. The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media. J. Assoc. Res. Otolaryngol. 4 (2003) 130-138
65. Harkness J.E., and Wagner J.E. Self-mutilation in mice associated with otitis media. Lab. Anim. Sci. 25 (1975) 315-318
66. Harris S.B., Glazier R., Eng K., and McMurray L. Disease patterns among Canadian aboriginal children. Study in a remote rural setting. Can. Fam. Physician 44 (1998) 1869-1877
67. Hays J.P., van Selm S., Hoogenboezem T., Estevao S., Eadie K., van Veelen P., Tommassen J., van Belkum A., and Hermans P.W. Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms. J. Bacteriol. 187 (2005) 7977-7984
68. Haziot A., Hijiya N., Gangloff S.C., Silver J., and Goyert S.M. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in cd14-deficient and toll-like receptor 4-deficient mice. J. Immunol. 166 (2001) 1075-1078
69. Heikkinen T. The role of respiratory viruses in otitis media. Vaccine 19 Suppl. 1 (2000) S51-55
70. Henry K.R., and Chole R.A. Genetic and functional analysis of the otosclerosis-like condition of the LP/J mouse. Audiology 26 (1987) 44-55
71. Hernandez M., Leichtle A., Pak K., Ebmeyer J., Euteneuer S., Obonyo M., Guiney D.G., Webster N.J., Broide D.H., Ryan A.F., and Wasserman S.I. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J. Infect. Dis. 198 (2008) 1862-1869
72. Hirano T., Kurono Y., Ichimiya I., Suzuki M., and Mogi G. Effects of influenza a virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization. Otolaryngol. Head Neck Surg. 121 (1999) 616-621
73. Hirano T., Kodama S., Fujita K., Maeda K., and Suzuki M. Role of toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media. FEMS Immunol. Med. Microbiol. 49 (2007) 75-83
74. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., and Vogel S.N. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69 (2001) 1477-1482
75. Holmes A.R., McNab R., Millsap K.W., Rohde M., Hammerschmidt S., Mawdsley J.L., and Jenkinson H.F. The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol. Microbiol. 41 (2001) 1395-1408
76. Hotomi M., Saito T., and Yamanaka N. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein p6 and cholera toxin. Vaccine 16 (1998) 1950-1956
77. Hotomi M., Yamanaka N., Shimada J., Suzumoto M., Ikeda Y., Sakai A., Arai J., and Green B. Intranasal immunization with recombinant outer membrane protein p6 induces specific immune responses against nontypeable Haemophilus influenzae. Int. J. Pediatr. Otorhinolaryngol. 65 (2002) 109-116
78. Hrabe de Angelis M.H., Flaswinkel H., Fuchs H., Rathkolb B., Soewarto D., Marschall S., Heffner S., Pargent W., Wuensch K., Jung M., Reis A., Richter T., Alessandrini F., Jakob T., Fuchs E., Kolb H., Kremmer E., Schaeble K., Rollinski B., Roscher A., Peters C., Meitinger T., Strom T., Steckler T., Holsboer F., Klopstock T., Gekeler F., Schindewolf C., Jung T., Avraham K., Behrendt H., Ring J., Zimmer A., Schughart K., Pfeffer K., Wolf E., and Balling R. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25 (2000) 444-447
79. Hunter A.G., Bankier A., Rogers J.G., Sillence D., and Scott Jr. C.I. Medical complications of achondroplasia: a multicentre patient review. J. Med. Genet. 35 (1998) 705-712
80. Ichimiya I., Suzuki M., Hirano T., and Mogi G. The influence of pneumococcal otitis media on the cochlear lateral wall. Hear. Res. 131 (1999) 128-134
81. Ichimiya I., Yoshida K., Hirano T., Suzuki M., and Mogi G. Significance of spiral ligament fibrocytes with cochlear inflammation. Int. J. Pediatr. Otorhinolaryngol. 56 (2000) 45-51
82. Ichimiya I., Yoshida K., Suzuki M., and Mogi G. Expression of adhesion molecules by cultured spiral ligament fibrocytes stimulated with proinflammatory cytokines. Ann. Otol. Rhinol. Laryngol. 112 (2003) 722-728
83. Jewett B.S., Prazma J.P., Hunter S.E., Rose A.S., Clark J.M., Sartor B.R., and Pillsbury H.C. Systemic reactivation of otitis media with effusion in a rat model. Otolaryngol. Head Neck Surg. 121 (1999) 7-12
84. Jin Shin D., Gan-Undram S., Jin Kim S., Joon Jun Y., Jung Im G., and Hyun Jung H. Expression of beta-defensins in the tubotympanum of experimental otitis media. Acta Otolaryngol. 126 (2006) 1040-1045
85. Johnson M., Leonard G., and Kreutzer D.L. Murine model of interleukin-8-induced otitis media. Laryngoscope 107 (1997) 1405-1408
86. Joki-Erkkila V.P., Puhakka H., and Hurme M. Cytokine gene polymorphism in recurrent acute otitis media. Arch. Otolarygol. Head Neck Surg. 128 (2002) 17-20
87. Juhn S.K., Jung T.T., Lin J., and Rhee C.K. Effects of inflammatory mediators on middle ear pathology and on inner ear function. Ann. N. Y. Acad. Sci. 830 (1997) 130-142
88. Kataoka Y., Haritani M., Mori M., Kishima M., Sugimoto C., Nakazawa M., and Yamamoto K. Experimental infections of mice and pigs with Streptococcus suis type 2. J. Vet. Med. Sci. 53 (1991) 1043-1049
89. Klingman K.L., and Murphy T.F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (branhamella) catarrhalis. Infect. Immun. 62 (1994) 1150-1155
90. Kodama S., Suenaga S., Hirano T., Suzuki M., and Mogi G. Induction of specific immunoglobulin A and Th2 immune responses to p6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect. Immun. 68 (2000) 2294-2300
91. Kodama S., Hirano T., Suenaga S., Abe N., and Suzuki M. Eustachian tube possesses immunological characteristics as a mucosal effector site and responds to p6 outer membrane protein of nontypeable Haemophilus influenzae. Vaccine 24 (2006) 1016-1027
92. Kodama S., Hirano T., Abe N., and Suzuki M. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal igA responses in the middle ear. Acta Otolaryngol. 127 (2007) 809-815
93. Koga T., Lim J.H., Jono H., Ha U.H., Xu H., Ishinaga H., Morino S., Xu X., Yan C., Kai H., and Li J.D. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling. J. Biol. Chem. 283 (2008) 12546-12554
94. Krekorian T.D., Keithley E.M., Takahashi M., Fierer J., and Harris J.P. Endotoxin-induced otitis media with effusion in the mouse. Immunohistochemical analysis. Acta Otolaryngol. 109 (1990) 288-299
95. Krekorian T.D., Keithley E.M., Fierer J., and Harris J.P. Type B Haemophilus influenzae-induced otitis media in the mouse. Laryngoscope 101 (1991) 648-656
96. Ku C.L., von Bernuth H., Picard C., Zhang S.Y., Chang H.H., Yang K., Chrabieh M., Issekutz A.C., Cunningham C.K., Gallin J., Holland S.M., Roifman C., Ehl S., Smart J., Tang M., Barrat F.J., Levy O., McDonald D., Day-Good N.K., Miller R., Takada H., Hara T., Al-Hajjar S., Al-Ghonaium A., Speert D., Sanlaville D., Li X., Geissmann F., Vivier E., Marodi L., Garty B.Z., Chapel H., Rodriguez-Gallego C., Bossuyt X., Abel L., Puel A., and Casanova J.L. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204 (2007) 2407-2422
97. Kubba H., Pearson J.P., and Birchall J.P. The aetiology of otitis media with effusion: a review. Clin. Otolaryngol. 25 (2000) 181-194
98. Kurono Y., Shimamura K., and Mogi G. Inhibition of nasopharyngeal colonization of Haemophilus influenzae by oral immunization. Ann. Otol. Rhinol. Laryngol. Suppl. 157 (1992) 11-15
99. Kurono Y., Bakaletz L.O., and Lim D.J. Inhibition of the adherence of Streptococcus pneumoniae to buccal epithelia cells in balb/c mice by oral immunization. In: Lim D.J. (Ed). Recent advances in otitis media (1993), Decker 206-208
100. Kweon S.M., Wang B., Rixter D., Lim J.H., Koga T., Ishinaga H., Chen L.F., Jono H., Xu H., and Li J.D. Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK. Biochem. Biophys. Res. Commun. 351 (2006) 368-375
101. Kyd J.M., Dunkley M.L., and Cripps A.W. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with p6 in a rat model. Infect. Immun. 63 (1995) 2931-2940
102. Kyd J., John A., Cripps A., and Murphy T.F. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (branhamella) catarrhalis. Vaccine 18 (1999) 398-406
103. Leichtle, A., Hernandez, M., Pak, K., Yamasaki, K., Cheng, C.-F., Webster, N. J., Ryan, A. F., Wasserman, S. I., in press. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immunity.
104. Liao J., Kochilas L., Nowotschin S., Arnold J.S., Aggarwal V.S., Epstein J.A., Brown M.C., Adams J., and Morrow B.E. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum. Mol. Genet. 13 (2004) 1577-1585
105. Lindberg K., Rynnel-Dagoo B., and Sundqvist K.G. Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media. Clin. Exp. Immunol. 97 (1994) 396-402
106. Loeb M.R. Protection of infant rats from Haemophilus influenzae type B infection by antiserum to purified outer membrane protein a. Infect. Immun. 55 (1987) 2612-2618
107. Lorenz E., Hallman M., Marttila R., Haataja R., and Schwartz D.A. Association between the asp299gly polymorphisms in the toll-like receptor 4 and premature births in the Finnish population. Pediatr. Res. 52 (2002) 373-376
108. Lorenz E., Jones M., Wohlford-Lenane C., Meyer N., Frees K.L., Arbour N.C., and Schwartz D.A. Genes other than TLR4 are involved in the response to inhaled LPS. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L1106-1114
109. Lorenz E., Mira J.P., Frees K.L., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162 (2002) 1028-1032
110. MacAndie C., and O'Reilly B.F. Sensorineural hearing loss in chronic otitis media. Clin. Otolaryngol. Allied Sci. 24 (1999) 220-222
111. MacArthur C.J., and Trune D.R. Mouse models of otitis media. Curr. Opin. Otolaryngol. Head Neck Surg. 14 (2006) 341-346
112. MacArthur C.J., Hefeneider S.H., Kempton J.B., Parrish S.K., McCoy S.L., and Trune D.R. Evaluation of the mouse model for acute otitis media. Hear. Res. 219 (2006) 12-23
113. MacArthur C.J., Hefeneider S.H., Kempton J.B., and Trune D.R. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope 116 (2006) 1071-1079
114. MacArthur C.J., Pillers D.A., Pang J., Degagne J.M., Kempton J.B., and Trune D.R. Gram-negative pathogen Klebsiella oxytoca is associated with spontaneous chronic otitis media in toll-like receptor 4-deficient C3H/HeJ mice. Acta Otolaryngol. 128 (2008) 132-138
115. MacArthur, C. J., Kempton, J. B., DeGagne, J. M., Trune, D. R., 2008b. Steroid control of chronic otitis media and sensorineural hearing loss in c3h/hej mice: glucocorticoids vs. mineralocorticoids. Otolaryngol. Head Neck Surg. 139, 646-653.
116. MacArthur, C. J., Kempton, J. B., DeGagne, J. M., Trune, D. R., in press. Steroid control of acute middle ear inflammation in the mouse. Arch. Otolarygol. Head Neck Surg.
117. Mashimo T., Lucas M., Simon-Chazottes D., Frenkiel M.P., Montagutelli X., Ceccaldi P.E., Deubel V., Guenet J.L., and Despres P. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11311-11316
118. Maxwell K., Leonard G., and Kreutzer D.L. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch. Otolarygol. Head Neck Surg. 123 (1997) 984-988
119. McGinn M.D., Bean-Knudsen D., and Ermel R.W. Incidence of otitis media in CBA/J and CBA/CaJ mice. Hear. Res. 59 (1992) 1-6
120. McMichael J.C. Vaccines for Moraxella catarrhalis. Vaccine 19 (2000) S101-107
121. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., and Janeway Jr. C.A. MyD88 is an adaptor protein in the hToll/iL-1 receptor family signaling pathways. Mol. Cell 2 (1998) 253-258
122. Meek III R.B., McGrew B.M., Cuff C.F., Berrebi A.S., Spirou G.A., and Wetmore S.J. Immunologic and histologic observations in reovirus-induced otitis media in the mouse. Ann. Otol. Rhinol. Laryngol. 108 (1999) 31-38
123. Melhus A., and Ryan A.F. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect. Immun. 68 (2000) 4024-4031
124. Melhus A., and Ryan A.F. Expression of molecular markers for bone formation increases during experimental acute otitis media. Microb. Pathog. 30 (2001) 111-120
125. Melhus A., and Ryan A.F. A mouse model for acute otitis media. Apmis 111 (2003) 989-994
126. Meyerhoff W.L., Kim C.S., and Paparella M.M. Pathology of chronic otitis media. Ann. Otol. Rhinol. Laryngol. 87 (1978) 749-760
127. Mitchell C.R., Kempton J.B., Scott-Tyler B., and Trune D.R. Otitis media incidence and impact on the auditory brain stem response in lipopolysaccharide-nonresponsive C3H/HeJ mice. Otolaryngol. Head Neck Surg. 117 (1997) 459-464
128. Moon S.K., Lee H.Y., Pan H., Takeshita T., Park R., Cha K., Andalibi A., and Lim D.J. Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells. BMC Infect. Dis. 6 (2006) 12
129. Moon S.K., Woo J.I., Lee H.Y., Park R., Shimada J., Pan H., Gellibolian R., and Lim D.J. Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Infect. Immun. 75 (2007) 3361-3372
130. Murphy T.F., Kirkham C., DeNardin E., and Sethi S. Analysis of antigenic structure and human immune response to outer membrane protein cd of Moraxella catarrhalis. Infect. Immun. 67 (1999) 4578-4585
131. Murphy T.F., Bakaletz L.O., Kyd J.M., Watson B., and Klein D.L. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23 (2005) 2696-2702
132. Mygind N., and Pedersen M. Nose-, sinus- and ear-symptoms in 27 patients with primary ciliary dyskinesia. Eur. J. Respir. Dis. Suppl. 127 (1983) 96-101
133. Nassif P.S., Simpson S.Q., Izzo A.A., and Nicklaus P.J. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope 107 (1997) 1223-1227
134. Nolan P.M., Peters J., Strivens M., Rogers D., Hagan J., Spurr N., Gray I.C., Vizor L., Brooker D., Whitehill E., Washbourne R., Hough T., Greenaway S., Hewitt M., Liu X., McCormack S., Pickford K., Selley R., Wells C., Tymowska-Lalanne Z., Roby P., Glenister P., Thornton C., Thaung C., Stevenson J.A., Arkell R., Mburu P., Hardisty R., Kiernan A., Erven A., Steel K.P., Voegeling S., Guenet J.L., Nickols C., Sadri R., Nasse M., Isaacs A., Davies K., Browne M., Fisher E.M., Martin J., Rastan S., Brown S.D., and Hunter J. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25 (2000) 440-443
135. Olbrich H., Haffner K., Kispert A., Volkel A., Volz A., Sasmaz G., Reinhardt R., Hennig S., Lehrach H., Konietzko N., Zariwala M., Noone P.G., Knowles M., Mitchison H.M., Meeks M., Chung E.M., Hildebrandt F., Sudbrak R., and Omran H. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat. Genet. 30 (2002) 143-144
136. Paparella M.M., Morizono T., Le C.T., Mancini F., Sipila P., Choo Y.B., Liden G., and Kim C.S. Sensorineural hearing loss in otitis media. Ann. Otol. Rhinol. Laryngol. 93 (1984) 623-629
137. Paparella M.M., Oda M., Hiraide F., and Brady D. Pathology of sensorineural hearing loss in otitis media. Ann. Otol. Rhinol. Laryngol. 81 (1972) 632-647
138. Papp Z., Rezes S., Jokay I., and Sziklai I. Sensorineural hearing loss in chronic otitis media. Otol. Neurotol. 24 (2003) 141-144
139. Parkinson, N., Brown, S. D., 2002. Focusing on the genetics of hearing: You ain't heard nothin' yet. Genome Biology COMMENT, 20061-20066.
140. Parkinson N., Hardisty-Hughes R.E., Tateossian H., Tsai H.T., Brooker D., Morse S., Lalane Z., MacKenzie F., Fray M., Glenister P., Woodward A.M., Polley S., Barbaric I., Dear N., Hough T.A., Hunter A.J., Cheeseman M.T., and Brown S.D. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet 2 (2006) e149
141. Patel J.A., Nair S., Revai K., Grady J., Saeed K., Matalon R., Block S., and Chonmaitree T. Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics 118 (2006) 2273-2279
142. Perelygin A.A., Scherbik S.V., Zhulin I.B., Stockman B.M., Li Y., and Brinton M.A. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9322-9327
143. Pettigrew M.M., Gent J.F., Zhu Y., Triche E.W., Belanger K.D., Holford T.R., Bracken M.B., and Leaderer B.P. Association of surfactant protein a polymorphisms with otitis media in infants at risk for asthma. BMC Med. Genet. 7 (2006) 68
144. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and c57bl/10sccr mice: mutations in TLR4 gene. Science 282 (1998) 2085-2088
145. Preciado D., Lin J., Wuertz B., and Rose M. Cigarette smoke activates NF kappa B and induces muc5b expression in mouse middle ear cells. Laryngoscope 118 (2008) 464-471
146. Prince J.E., Brayton C.F., Fossett M.C., Durand J.A., Kaplan S.L., Smith C.W., and Ballantyne C.M. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae. J. Immunol. 166 (2001) 7362-7369
147. Pugin J., Schurer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., and Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2744-2748
148. Ramet M., Lofgren J., Alho O.P., and Hallman M. Surfactant protein-a gene locus associated with recurrent otitis media. J. Pediatr. 138 (2001) 266-268
149. Rivkin A.Z., Palacios S.D., Pak K., Bennett T., and Ryan A.F. The role of FAS-mediated apoptosis in otitis media: observations in the lpr/lpr mouse. Hear. Res. 207 (2005) 110-116
150. Roche A.M., King S.J., and Weiser J.N. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75 (2007) 2469-2475
151. Ryan A.F., Sharp P.A., and Harris J.P. Lymphocyte circulation to the middle ear. Acta Otolaryngol. 109 (1990) 278-287
152. Ryan A.F., Ebmeyer J., Furukawa M., Pak K., Melhus A., Wasserman S.I., and Chung W.H. Mouse models of induced otitis media. Brain Res. 1091 (2006) 3-8
153. Ryding M., Konradsson K., Kalm O., and Prellner K. Auditory consequences of recurrent acute purulent otitis media. Ann. Otol. Rhinol. Laryngol. 111 (2002) 261-266
154. Sabirov A., and Metzger D.W. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Vaccine 24 (2006) 5584-5592
155. Sabirov A., and Metzger D.W. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue. Vaccine 26 (2008) 1566-1576
156. Sabirov A., and Metzger D.W. Mouse models for the study of mucosal vaccination against otitis media. Vaccine 26 (2008) 1501-1524
157. Sabirov A., Kodama S., Hirano T., Suzuki M., and Mogi G. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect. Immun. 69 (2001) 2964-2971
158. Sabroe I., Read R.C., Whyte M.K., Dockrell D.H., Vogel S.N., and Dower S.K. Toll-like receptors in health and disease: complex questions remain. J. Immunol. 171 (2003) 1630-1635
159. Sarwar J., Campagnari A.A., Kirkham C., and Murphy T.F. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60 (1992) 804-809
160. Schachern P.A., Cureoglu S., Tsuprun V., Paparella M.M., and Whitley C.B. Age-related functional and histopathological changes of the ear in the mps i mouse. Int. J. Pediatr. Otorhinolaryngol. 71 (2007) 197-203
161. Schroder N.W., and Schumann R.R. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
162. Schwartz D.A. The genetics of innate immunity. Chest 121 (2002) 62S-68S
163. Segade F., Daly K.A., Allred D., Hicks P.J., Cox M., Brown M., Hardisty-Hughes R.E., Brown S.D., Rich S.S., and Bowden D.W. Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media: the Minnesota COME/ROM family study. Arch. Otolaryngol. Head Neck Surg. 132 (2006) 729-733
164. Shimada, J., Moon, S.K., Lee, H.Y., Takeshita, T., Pan, H., Woo, J.I., Gellibolian, R., Yamanaka, N., Lim, D.J., 2008. Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect. Dis. 8, 134.
165. Shuto T., Xu H., Wang B., Han J., Kai H., Gu X.X., Murphy T.F., Lim D.J., and Li J.D. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and mkk3/6-p38 map kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8774-8779
166. Smirnova M.G., Kiselev S.L., Gnuchev N.V., Birchall J.P., and Pearson J.P. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion. Eur. Cytokine Netw. 13 (2002) 161-172
167. Sorri M., Maki-Torkko E., and Alho O.P. Otitis media and long-term follow-up of hearing. Acta Otolaryngol. 115 (1995) 193-195
168. Steel K.P., Moorjani P., and Bock G.R. Mixed conductive and sensorineural hearing loss in LP/J mice. Hear. Res. 28 (1987) 227-236
169. Storgaard M., Larsen K., Blegvad S., Nodgaard H., Ovesen T., Andersen P.L., and Obel N. Interleukin-8 and chemotactic activity of middle ear effusions. J. Infect. Dis. 175 (1997) 474-477
170. Sudhoff H., Dazert S., Gonzales A.M., Borkowski G., Park S.Y., Baird A., Hildmann H., and Ryan A.F. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am. J. Otol. 21 (2000) 793-798
171. Sun K., Johansen F.-E., Eckmann L., and Metzger D.W. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J. Immunol. 173 (2004) 4576-4581
172. Tak P.P., and Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107 (2001) 7-11
173. Takahashi M., Kanai N., Watanabe A., Oshima O., and Ryan A.F. Lymphocyte subsets in immune-mediated otitis media with effusion. Eur. Arch. Otorhinolaryngol. 249 (1992) 24-27
174. Takeshita F., Gursel I., Ishii K.J., Suzuki K., Gursel M., and Klinman D.M. Signal transduction pathways mediated by the interaction of CpG DNA with toll-like receptor 9. Semin. Immunol. 16 (2004) 17-22
175. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
176. Thalmann, I., 2006. Inner ear proteomics: a fad or hear to stay. Brain Res. 1091 (1), 103-112.
177. Thomas K.R., and Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51 (1987) 503-512
178. Todd N.W. Familial predisposition for otitis media in Apache Indians at Canyon Day, Arizona. Genet. Epidemiol. 4 (1987) 25-31
179. Tsuchiya K., Kim Y., Ondrey F.G., and Lin J. Characterization of a temperature-sensitive mouse middle ear epithelial cell line. Acta Otolaryngol. 125 (2005) 823-829
180. Vaughan K.T., Mikami A., Paschal B.M., Holzbaur E.L., Hughes S.M., Echeverri C.J., Moore K.J., Gilbert D.J., Copeland N.G., Jenkins N.A., and Vallee R.B. Multiple mouse chromosomal loci for dynein-based motility. Genomics 36 (1996) 29-38
181. Viswanathan S., Unlu M., and Minden J.S. Two-dimensional difference gel electrophoresis. Nat. Protoc. 1 (2006) 1351-1358
182. Wallace F.J., Clancy R.L., and Cripps A.W. An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue. Am. Rev. Respir. Dis. 140 (1989) 311-316
183. Wang B., Lim D.J., Han J., Kim Y.S., Basbaum C.B., and Li J.D. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J. Biol. Chem. 277 (2002) 949-957
184. Ward J.M., Houchens D.P., Collins M.J., Young D.M., and Reagan R.L. Naturally-occurring Sendai virus infection of athymic nude mice. Vet. Pathol. 13 (1976) 36-46
185. Watanabe T., Hirano T., Suzuki M., Kurono Y., and Mogi G. Role of interleukin-1beta in a murine model of otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 110 (2001) 574-580
186. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., Agarwala R., Ainscough R., Alexandersson M., An P., Antonarakis S.E., Attwood J., Baertsch R., Bailey J., Barlow K., Beck S., Berry E., Birren B., Bloom T., Bork P., Botcherby M., Bray N., Brent M.R., Brown D.G., Brown S.D., Bult C., Burton J., Butler J., Campbell R.D., Carninci P., Cawley S., Chiaromonte F., Chinwalla A.T., Church D.M., Clamp M., Clee C., Collins F.S., Cook L.L., Copley R.R., Coulson A., Couronne O., Cuff J., Curwen V., Cutts T., Daly M., David R., Davies J., Delehaunty K.D., Deri J., Dermitzakis E.T., Dewey C., Dickens N.J., Diekhans M., Dodge S., Dubchak I., Dunn D.M., Eddy S.R., Elnitski L., Emes R.D., Eswara P., Eyras E., Felsenfeld A., Fewell G.A., Flicek P., Foley K., Frankel W.N., Fulton L.A., Fulton R.S., Furey T.S., Gage D., Gibbs R.A., Glusman G., Gnerre S., Goldman N., Goodstadt L., Grafham D., Graves T.A., Green E.D., Gregory S., Guigo R., Guyer M., Hardison R.C., Haussler D., Hayashizaki Y., Hillier L.W., Hinrichs A., Hlavina W., Holzer T., Hsu F., Hua A., Hubbard T., Hunt A., Jackson I., Jaffe D.B., Johnson L.S., Jones M., Jones T.A., Joy A., Kamal M., Karlsson E.K., Karolchik D., Kasprzyk A., Kawai J., Keibler E., Kells C., Kent W.J., Kirby A., Kolbe D.L., Korf I., Kucherlapati R.S., Kulbokas E.J., Kulp D., Landers T., Leger J.P., Leonard S., Letunic I., Levine R., Li J., Li M., Lloyd C., Lucas S., Ma B., Maglott D.R., Mardis E.R., Matthews L., Mauceli E., Mayer J.H., McCarthy M., McCombie W.R., McLaren S., McLay K., McPherson J.D., Meldrim J., Meredith B., Mesirov J.P., Miller W., Miner T.L., Mongin E., Montgomery K.T., Morgan M., Mott R., Mullikin J.C., Muzny D.M., Nash W.E., Nelson J.O., Nhan M.N., Nicol R., Ning Z., Nusbaum C., O'Connor M.J., Okazaki Y., Oliver K., Overton-Larty E., Pachter L., Parra G., Pepin K.H., Peterson J., Pevzner P., Plumb R., Pohl C.S., Poliakov A., Ponce T.C., Ponting C.P., Potter S., Quail M., Reymond A., Roe B.A., Roskin K.M., Rubin E.M., Rust A.G., Santos R., Sapojnikov V., Schultz B., Schultz J., Schwartz M.S., Schwartz S., Scott C., Seaman S., Searle S., Sharpe T., Sheridan A., Shownkeen R., Sims S., Singer J.B., Slater G., Smit A., Smith D.R., Spencer B., Stabenau A., Stange-Thomann N., Sugnet C., Suyama M., Tesler G., Thompson J., Torrents D., Trevaskis E., Tromp J., Ucla C., Ureta-Vidal A., Vinson J.P., Von Niederhausern A.C., Wade C.M., Wall M., Weber R.J., Weiss R.B., Wendl M.C., West A.P., Wetterstrand K., Wheeler R., Whelan S., Wierzbowski J., Willey D., Williams S., Wilson R.K., Winter E., Worley K.C., Wyman D., Yang S., Yang S.P., Zdobnov E.M., Zody M.C., and Lander E.S. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002) 520-562
187. Whitfield T.T., Mburu P., Hardisty-Hughes R.E., and Brown S.D.M. Models of congenital deafness. Drug Discovery Today 2 (2005) 85-91
188. Wiles M.V., Vauti F., Otte J., Fuchtbauer E.M., Ruiz P., Fuchtbauer A., Arnold H.H., Lehrach H., Metz T., von Melchner H., and Wurst W. Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat. Genet. 24 (2000) 13-14
189. Yamamoto M., McDaniel L.S., Kawabata K., Briles D.E., Jackson R.J., McGhee J.R., and Kiyono H. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect. Immun. 65 (1997) 640-644
190. Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., McKeon F., and Caput D. P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404 (2000) 99-103
191. Yoshida K., Ichimiya I., Suzuki M., and Mogi G. Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear. Res. 137 (1999) 155-159
192. Zhang S. An improved nonparametric approach for detecting differentially expressed genes with replicated microarray data. Stat. Appl. Genet. Mol. Biol. 5 (2006) Article30
193. Zheng Q.Y., and Johnson K.R. Hearing loss associated with the modifier of deaf waddler (mdfw) locus corresponds with age-related hearing loss in 12 inbred strains of mice. Hear. Res. 154 (2001) 45-53
194. Zheng Q.Y., Johnson K.R., and Erway L.C. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear. Res. 130 (1999) 94-107
195. Zheng Q.Y., Hardisty-Hughes R., and Brown S.D. Mouse models as a tool to unravel the genetic basis for human otitis media. Brain Res. 1091 1 (2006) 9-15 May 26
196. Zheng Q.Y., Rozanas C.R., Thalmann I., Chance M.R., and Alagramam K.N. Inner ear proteomics of mouse models for deafness, a discovery strategy. Brain Res. 1091 (2006) 113-121
197. Zheng Q.Y., Tong Y.C., Alagramam K.N., and Yu H. Tympanometry assessment of 61 inbred strains of mice. Hear Res. Hear Res. 231 1-2 (2007) 23-31 Sep